K. Elliott

Two mutations in troponin I that cause hypertrophic cardiomyopathy have contrasting effects on cardiac muscle contractility.

H. Watkins, Steven B Marston, C. Redwood, 2002, The Biochemical journal.

Defective inhibitory properties of human cardiac troponin I mutants that cause familial hypertrophic cardiomyopathy (FHC)

H. Watkins, C. Redwood, K. Elliott, 1998 .

Investigation of a truncated cardiac troponin T that causes familial hypertrophic cardiomyopathy: Ca(2+) regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild-type protein.

H. Watkins, G. Esposito, Steven B Marston, 2000, Circulation research.

Novel variants in KAT6B spectrum of disorders expand our knowledge of clinical manifestations and molecular mechanisms

Jill A. Madden, E. Roeder, A. Fatemi, 2021, Molecular genetics & genomic medicine.

Metabolic Profiling of Aortic Stenosis and Hypertrophic Cardiomyopathy Identifies Mechanistic Contrasts in Substrate Utilisation

B. Prendergast, H. Watkins, H. Lockstone, 2019, bioRxiv.

Altered Regulatory Properties of Human Cardiac Troponin I Mutants That Cause Hypertrophic Cardiomyopathy*

H. Watkins, C. Redwood, H Watkins, 2000, The Journal of Biological Chemistry.